Stryker Q2 FY25: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Aug 1, 2025
Revenue$6.02B
+11% year over year
Gross profit$3.84B
64% margin
Operating profit$1.11B
18% margin
Net profit$0.88B
15% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 6.02 | 100% | +11% |
| Med surg & neurotechnology | 3.77 | 63% | +17% |
| Orthopaedics & spine | 2.25 | 37% | +2% |
| Cost of revenue | −2.18 | 36% | |
| Gross profit | 3.84 | 64% margin | +1pp |
| R&D | −0.41 | 7% | +0pp |
| SG&A | −2.08 | 34% | +1pp |
| Other | −0.24 | 4% | +0pp |
| Operating profit | 1.11 | 18% margin | −1pp |
| Interest & other costs | −0.10 | ||
| Tax | −0.13 | ||
| Net profit | 0.88 | 15% margin | −1pp |
209 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest